Coronary artery-bypass-graft surgery increases the plasma concentration of exosomes carrying a cargo of cardiac microRNAs: An example of exosome trafficking out of the human heart with potential for cardiac biomarker discovery

PLoS ONE

Volumn 11, Issue 4, 2016, Pages

  Emanueli, Costanza ^a,b   Shearn, Andrew I U ^a   Laftah, Abas ^b   Fiorentino, Francesca ^b   Reeves, Barnaby C ^a   Beltrami, Cristina ^a   Mumford, Andrew ^a   Clayton, Aled ^c   Gurney, Mark ^c   Shantikumar, Saran ^a   Angelini, Gianni D ^a,b  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

^b NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

^c CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

MICRORNA; MICRORNA 1; MICRORNA 122; MICRORNA 133A; MICRORNA 133B; MICRORNA 208A; MICRORNA 208B; MICRORNA 210; MICRORNA 24; NANOPARTICLE; UNCLASSIFIED DRUG; BIOLOGICAL MARKER; TROPONIN I;

ADULT; AGED; ARTICLE; CARDIAC MUSCLE CELL; CARDIAC PATIENT; CELL MIGRATION; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; ENZYME LINKED IMMUNOSORBENT ASSAY; EXOSOME; FEMALE; HEART MUSCLE INJURY; HUMAN; HYPOXIA; IN VITRO STUDY; LINEAR REGRESSION ANALYSIS; MALE; OBSERVATIONAL STUDY; PERIPHERAL CIRCULATION; PROSPECTIVE STUDY; QUALITY CONTROL; BLOOD; CARDIAC MUSCLE; CORONARY BLOOD VESSEL; METABOLISM; MIDDLE AGED; PATHOLOGY; SECRETION (PROCESS); STATISTICAL MODEL; SURGERY;

AGED; BIOMARKERS; CORONARY ARTERY BYPASS; CORONARY VESSELS; EXOSOMES; FEMALE; HUMANS; LINEAR MODELS; MALE; MICRORNAS; MIDDLE AGED; MYOCARDIUM; PROSPECTIVE STUDIES; TROPONIN I;

EID: 84966930089     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0154274     Document Type: Article

References (48)

1. Boon RA, Vickers KC. Intercellular transport of microRNAs. Arteriosclerosis, thrombosis, and vascular biology. 2013; 33(2):186-92. doi: 10.1161/ATVBAHA.112.300139 PMID: 23325475; PubMed Central PMCID: PMC3580056.
2. Emanueli C, Shearn AI, Angelini GD, Sahoo S. Exosomes and exosomal miRNAs in cardiovascular protection and repair. Vascular pharmacology. 2015. doi: 10.1016/j.vph.2015.02.008 PMID: 25869502.
3. Cocucci E, Meldolesi J. Ectosomes and exosomes: shedding the confusion between extracellular vesicles. Trends in cell biology. 2015; 25(6):364-72. doi: 10.1016/j.tcb.2015.01.004 PMID: 25683921.
4. Subra C, Grand D, Laulagnier K, Stella A, Lambeau G, Paillasse M, et al. Exosomes account for vesicle-mediated transcellular transport of activatable phospholipases and prostaglandins. Journal of lipid research. 2010; 51(8):2105-20. doi: 10.1194/jlr.M003657 PMID: 20424270; PubMed Central PMCID: PMC2903822.
5. Raposo G, Nijman HW, Stoorvogel W, Liejendekker R, Harding CV, Melief CJ, et al. B lymphocytes secrete antigen-presenting vesicles. The Journal of experimental medicine. 1996; 183(3):1161-72. PMID: 8642258; PubMed Central PMCID: PMC2192324.
6. Thery C, Amigorena S, Raposo G, Clayton A. Isolation and characterization of exosomes from cell culture supernatants and biological fluids. Current protocols in cell biology / editorial board, Juan S Bonifacino [et al]. 2006;Chapter 3:Unit 3 22. doi: 10.1002/0471143030.cb0322s30 PMID: 18228490.
7. Yu X, Deng L, Wang D, Li N, Chen X, Cheng X, et al. Mechanism of TNF-alpha autocrine effects in hypoxic cardiomyocytes: initiated by hypoxia inducible factor 1alpha, presented by exosomes. Journal of molecular and cellular cardiology. 2012; 53(6):848-57. doi: 10.1016/j.yjmcc.2012.10.002 PMID: 23085511.
8. de Jong OG, Verhaar MC, Chen Y, Vader P, Gremmels H, Posthuma G, et al. Cellular stress conditions are reflected in the protein and RNA content of endothelial cell-derived exosomes. Journal of extracellular vesicles. 2012; 1. doi: 10.3402/jev.v1i0.18396 PMID: 24009886; PubMed Central PMCID: PMC3760650.
9. Garcia NA, Ontoria-Oviedo I, Gonzalez-King H, Diez-Juan A, Sepulveda P. Glucose Starvation in Cardiomyocytes Enhances Exosome Secretion and Promotes Angiogenesis in Endothelial Cells. PloS one. 2015; 10(9):e0138849. doi: 10.1371/journal.pone.0138849 PMID: 26393803; PubMed Central PMCID: PMC4578916.
10. Wang X, Huang W, Liu G, Cai W, Millard RW, Wang Y, et al. Cardiomyocytes mediate anti-angiogenesis in type 2 diabetic rats through the exosomal transfer of miR-320 into endothelial cells. Journal of molecular and cellular cardiology. 2014; 74:139-50. doi: 10.1016/j.yjmcc.2014.05.001 PMID: 24825548; PubMed Central PMCID: PMC4120246.
11. Bang C, Batkai S, Dangwal S, Gupta SK, Foinquinos A, Holzmann A, et al. Cardiac fibroblast-derived microRNA passenger strand-enriched exosomes mediate cardiomyocyte hypertrophy. The Journal of clinical investigation. 2014; 124(5):2136-46. doi: 10.1172/JCI70577 PMID: 24743145; PubMed Central PMCID: PMC4001534.
12. Hergenreider E, Heydt S, Treguer K, Boettger T, Horrevoets AJ, Zeiher AM, et al. Atheroprotective communication between endothelial cells and smooth muscle cells through miRNAs. Nature cell biology. 2012; 14(3):249-56. doi: 10.1038/ncb2441 PMID: 22327366.
13. Hoshino A C-SB, Shen T-L, Rodrigues G, Hashimoto A et al. Tumour exosome integrins determine organotropic metastasis. Nature. 2015. doi: 10.1038/nature15756
14. Hoshino A, Costa-Silva B, Shen TL, Rodrigues G, Hashimoto A, Tesic Mark M, et al. Tumour exosome integrins determine organotropic metastasis. Nature. 2015. doi: 10.1038/nature15756 PMID: 26524530.
15. D'Alessandra Y, Devanna P, Limana F, Straino S, Di Carlo A, Brambilla PG, et al. Circulating micro- RNAs are new and sensitive biomarkers of myocardial infarction. European heart journal. 2010; 31 (22):2765-73. doi: 10.1093/eurheartj/ehq167 PMID: 20534597; PubMed Central PMCID: PMC2980809.
16. Eitel I, Adams V, Dieterich P, Fuernau G, de Waha S, Desch S, et al. Relation of circulating MicroRNA-133a concentrations with myocardial damage and clinical prognosis in ST-elevation myocardial infarction. American heart journal. 2012; 164(5):706-14. doi: 10.1016/j.ahj.2012.08.004 PMID: 23137501.
17. Widera C, Gupta SK, Lorenzen JM, Bang C, Bauersachs J, Bethmann K, et al. Diagnostic and prognostic impact of six circulating microRNAs in acute coronary syndrome. Journal of molecular and cellular cardiology. 2011; 51(5):872-5. doi: 10.1016/j.yjmcc.2011.07.011 PMID: 21806992.
18. Chan YC, Banerjee J, Choi SY, Sen CK. miR-210: The Master Hypoxamir. Microcirculation. 2012; 19 (3):215-23. doi: 10.1111/j.1549-8719.2011.00154.x PMID: 22171547
19. Mutharasan RK, Nagpal V, Ichikawa Y, Ardehali H. microRNA-210 is upregulated in hypoxic cardiomyocytes through Akt- and p53-dependent pathways and exerts cytoprotective effects. American Journal of Physiology - Heart and Circulatory Physiology. 2011; 301(4):H1519-H30. doi: 10.1152/ajpheart.01080.2010 PMID: 21841015
20. Qiao A, Khechaduri A, Kannan Mutharasan R, Wu R, Nagpal V, Ardehali H. MicroRNA-210 Decreases heme Levels by Targeting Ferrochelatase in Cardiomyocytes. Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease. 2013; 2(2):e000121. doi: 10.1161/JAHA.113.000121 PMID: PMC3647255.
21. Greco S, Fasanaro P, Castelvecchio S, D'Alessandra Y, Arcelli D, Di Donato M, et al. MicroRNA Dysregulation in Diabetic Ischemic Heart Failure Patients. Diabetes. 2012; 61(6):1633-41. doi: 10.2337/db11-0952 PMID: 22427379
22. Fiedler J, Jazbutyte V, Kirchmaier BC, Gupta SK, Lorenzen J, Hartmann D, et al. MicroRNA-24 Regulates Vascularity After Myocardial Infarction. Circulation. 2011; 124(6):720-30. doi: 10.1161/circulationaha.111.039008 PMID: 21788589
23. Meloni M, Marchetti M, Garner K, Littlejohns B, Sala-Newby G, Xenophontos N, et al. Local Inhibition of MicroRNA-24 Improves Reparative Angiogenesis and Left Ventricle Remodeling and Function in Mice With Myocardial Infarction. Molecular Therapy. 2013; 21(7):1390-402. doi: 10.1038/mt.2013.89 PMID: PMC3702112.
24. Zhou X, Mao A, Wang X, Duan X, Yao Y, Zhang C. Urine and serum microRNA-1 as novel biomarkers for myocardial injury in open-heart surgeries with cardiopulmonary bypass. PloS one. 2013; 8(4): e62245. doi: 10.1371/journal.pone.0062245 PMID: 23630629; PubMed Central PMCID: PMC3632512.
25. Yang W, Shao J, Bai X, Zhang G. Expression of Plasma microRNA-1/21/208a/499 in Myocardial Ischemic Reperfusion Injury. Cardiology. 2015; 130(4):237-41. doi: 10.1159/000371792 PMID: 25791720.
26. Tsounis D, Deftereos S, Bouras G, Giannopoulos G, Anatoliotakis N, Raisakis K, et al. High sensitivity troponin in cardiovascular disease. Is there more than a marker of myocardial death? Current topics in medicinal chemistry. 2013; 13(2):201-15. PMID: 23470078.
27. Lucreziotti S, Foroni C, Fiorentini C. Perioperative myocardial infarction in noncardiac surgery: the diagnostic and prognostic role of cardiac troponins. Journal of internal medicine. 2002; 252(1):11-20. PMID: 12074733.
28. Carr B, Wright M. Nanoparticle Tracking Analysis - A Review of Applications and Usage 2010-2012: NanoSight Ltd; 2013.
29. Hodgson L, Tavaré J, Verkade P. Development of a quantitative Correlative Light Electron Microscopy technique to study GLUT4 trafficking. Protoplasma. 2014; 251(2):403-16. doi: 10.1007/s00709-013-0597-5 PMID: 24390248
30. Blondal T, Jensby Nielsen S, Baker A, Andreasen D, Mouritzen P, Wrang Teilum M, et al. Assessing sample and miRNA profile quality in serum and plasma or other biofluids. Methods. 2013; 59(1):S1-6. doi: 10.1016/j.ymeth.2012.09.015 PMID: 23036329.
31. Willeit P, Zampetaki A, Dudek K, Kaudewitz D, King A, Kirkby NS, et al. Circulating microRNAs as novel biomarkers for platelet activation. Circulation research. 2013; 112(4):595-600. doi: 10.1161/CIRCRESAHA.111.300539 PMID: 23283721.
32. Zhang YY, Zhou X, Ji WJ, Shi R, Lu RY, Li JL, et al. Decreased circulating microRNA-223 level predicts high on-treatment platelet reactivity in patients with troponin-negative non-ST elevation acute coronary syndrome. Journal of thrombosis and thrombolysis. 2014; 38(1):65-72. doi: 10.1007/s11239-013-1022-9 PMID: 24202700.
33. Tantry US, Bonello L, Aradi D, Price MJ, Jeong YH, Angiolillo DJ, et al. Consensus and update on the definition of on-treatment platelet reactivity to adenosine diphosphate associated with ischemia and bleeding. Journal of the American College of Cardiology. 2013; 62(24):2261-73. doi: 10.1016/j.jacc.2013.07.101 PMID: 24076493.
34. Kroh EM, Parkin RK, Mitchell PS, Tewari M. Analysis of circulating microRNA biomarkers in plasma and serum using quantitative reverse transcription-PCR (qRT-PCR). Methods. 2010; 50(4):298-301. doi: 10.1016/j.ymeth.2010.01.032 PMID: 20146939; PubMed Central PMCID: PMC4186708.
35. Liebetrau C, Mollmann H, Troidl C, Nef H. Reply: effects of heparin on temporal microRNA profiles. Journal of the American College of Cardiology. 2014; 63(9):941-2. doi: 10.1016/j.jacc.2013.09.077 PMID: 24315917.
36. Kirschner MB, Kao SC, Edelman JJ, Armstrong NJ, Vallely MP, van Zandwijk N, et al. Haemolysis during sample preparation alters microRNA content of plasma. PloS one. 2011; 6(9):e24145. doi: 10.1371/journal.pone.0024145 PMID: 21909417; PubMed Central PMCID: PMC3164711.
37. Loyer X, Vion AC, Tedgui A, Boulanger CM. Microvesicles as cell-cell messengers in cardiovascular diseases. Circulation research. 2014; 114(2):345-53. doi: 10.1161/CIRCRESAHA.113.300858 PMID: 24436430.
38. Dragovic RA, Gardiner C, Brooks AS, Tannetta DS, Ferguson DJ, Hole P, et al. Sizing and phenotyping of cellular vesicles using Nanoparticle Tracking Analysis. Nanomedicine: nanotechnology, biology, and medicine. 2011; 7(6):780-8. doi: 10.1016/j.nano.2011.04.003 PMID: 21601655; PubMed Central PMCID: PMC3280380.
39. van der Pol E, van Gemert MJ, Sturk A, Nieuwland R, van Leeuwen TG. Single vs. swarm detection of microparticles and exosomes by flow cytometry. Journal of thrombosis and haemostasis: JTH. 2012; 10(5):919-30. doi: 10.1111/j.1538-7836.2012.04683.x PMID: 22394434.
40. van der Vlist EJ, Nolte-'t Hoen EN, Stoorvogel W, Arkesteijn GJ, Wauben MH. Fluorescent labeling of nano-sized vesicles released by cells and subsequent quantitative and qualitative analysis by high-resolution flow cytometry. Nature protocols. 2012; 7(7):1311-26. doi: 10.1038/nprot.2012.065 PMID: 22722367.
41. Ueda K, Ishikawa N, Tatsuguchi A, Saichi N, Fujii R, Nakagawa H. Antibody-coupled monolithic silica microtips for highthroughput molecular profiling of circulating exosomes. Scientific reports. 2014; 4:6232. doi: 10.1038/srep06232 PMID: 25167841; PubMed Central PMCID: PMC4148700.
42. Logozzi M, De Milito A, Lugini L, Borghi M, Calabro L, Spada M, et al. High levels of exosomes expressing CD63 and caveolin-1 in plasma of melanoma patients. PloS one. 2009; 4(4):e5219. doi: 10.1371/journal.pone.0005219 PMID: 19381331; PubMed Central PMCID: PMC2667632.
43. Matsumoto S, Sakata Y, Suna S, Nakatani D, Usami M, Hara M, et al. Circulating p53-responsive microRNAs are predictive indicators of heart failure after acute myocardial infarction. Circulation research. 2013; 113(3):322-6. doi: 10.1161/CIRCRESAHA.113.301209 PMID: 23743335.
44. Xiang M, Zeng Y, Yang R, Xu H, Chen Z, Zhong J, et al. U6 is not a suitable endogenous control for the quantification of circulating microRNAs. Biochemical and biophysical research communications. 2014; 454(1):210-4. doi: 10.1016/j.bbrc.2014.10.064 PMID: 25450382.
45. Oerlemans MI, Mosterd A, Dekker MS, de Vrey EA, van Mil A, Pasterkamp G, et al. Early assessment of acute coronary syndromes in the emergency department: the potential diagnostic value of circulating microRNAs. EMBO molecular medicine. 2012; 4(11):1176-85. doi: 10.1002/emmm.201201749 PMID: 23023917; PubMed Central PMCID: PMC3494874.
46. Liebetrau C, Mollmann H, Dorr O, Szardien S, Troidl C, Willmer M, et al. Release kinetics of circulating muscle-enriched microRNAs in patients undergoing transcoronary ablation of septal hypertrophy. Journal of the American College of Cardiology. 2013; 62(11):992-8. doi: 10.1016/j.jacc.2013.05.025 PMID: 23747779.
47. Nabialek E, Wanha W, Kula D, Jadczyk T, Krajewska M, Kowalowka A, et al. Circulating microRNAs (miR-423-5p, miR-208a and miR-1) in acute myocardial infarction and stable coronary heart disease. Minerva cardioangiologica. 2013; 61(6):627-37. PMID: 24253456.
48. Arata H, Komatsu H, Hosokawa K, Maeda M. Rapid and sensitive microRNA detection with laminar flow-assisted dendritic amplification on power-free microfluidic chip. PloS one. 2012; 7(11):e48329. doi: 10.1371/journal.pone.0048329 PMID: 23144864; PubMed Central PMCID: PMC3492330.